Risk and impacts of drug-induced liver injury (DILI) due to immune-checkpoint inhibitors (ICI) on overall survival in patients with newly diagnosed cancer: A retrospective cohort study. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback